Quantitative T1 mapping reveals changes after COVID-19 in specific brain regions: a prospective observational case-control study
07:00Christophe Arendt, Frankfurt am Main / DE
4
FDG PET CT in the neurological complications of COVID-19
07:00Nikhil Seniaray, New Delhi / IN
5
Pre-and post-mortem MRI evaluation in COVID-19
07:00Simonetta Gerevini, Cremona / IT
6
Yield of high-resolution vessel wall magnetic resonance imaging in patients with tuberculous meningitis: a prospective study from a tertiary care hospital
07:00Shailly Sonker, Jodhpur / IN
7
Diagnostic Value of Gadolinium-Enhanced SWI Sequences in Multiple Sclerosis
07:00Cristina Fagotti, L'Aquila / IT
8
Estimation of white matter hyperintensities with synthetic MRI myelin volume fraction in patients with multiple sclerosis and non-MS white matter hyperintensities
07:00Nisha Syed Nasser, Delhi / IN
9
MR-Planimetry in multiple sclerosis: potential biomarker predicting clinical disease severity
07:00Stephanie Mangesius, Innsbruck / AT
10
Clinical validity of quantitative AI software-assisted monitoring in multiple sclerosis: comparison with neuroradiological visual assessment and clinical correlates
07:00Federico Bruno, L'Aquila / IT
11
Assessment of the agreement for detection of optic nerve lesions on 3D double inversion recovery sequence magnetic resonance imaging
07:00Hawa Kalamou, LILLE / FR
PEP Subscription Required
This course is only accessible for ESR Premium Education Package subscribers.